Beijing Konruns Pharmaceutical Corporation, based in Zhongguancun Science Park, has 48 intellectual properties and foreign patents from 12 countries.

Its major products include Diao, a medicine to slow tumors, and Suling, which prevents coagulation during operations. The corporation has three innovative medicines and has more than 10 projects under research. The corporation also produces a traditional Chinese medicine that cures gynecological diseases and has been registered as an innovative medicine.

The corporation has completed research in more than ten innovative medicines with intellectual properties. Five of them have been registered as innovative medicines and approved for production.

Suling, a major innovative medicine included in the National 863 Program, is the only one of its kind in the Chinese market with four global firsts. Diao has had great effects in clinical processes.